Trademark: 79392161
Word
ABSELION
Status
Pending
Status Code
641
Status Date
Friday, July 5, 2024
Serial Number
79392161
Mark Type
4
Filing Date
Monday, October 30, 2023

Trademark Owner History

Classifications
9 Laboratory apparatus and instruments; scientific research apparatus and instruments; apparatus and instruments for diagnosis [for scientific use]; laboratory instruments, namely, devices for molecular analysis of proteins; laboratory instruments for protein analysis including chemical and biochemical reactions; laboratory apparatus and instruments for biomolecular analysis; laboratory apparatus and instruments for the analysis of proteins; laboratory apparatus and instruments for the analysis of biomolecules and biological molecules; laboratory apparatus and instruments for genetic and DNA analysis; laboratory apparatus and instruments for the automation of biomolecular analysis; laboratory apparatus and instruments for the automation of protein analysis; laboratory apparatus and instruments for the automation of biomolecule and biological molecule analysis; laboratory apparatus and instruments for the automation of genetic and DNA analysis; laboratory apparatus and instruments for drug development and drug discovery in the field of biotechnology; robotic apparatus and instruments for biomolecular analysis; robotic apparatus and instruments for protein analysis; robotic apparatus and instruments for biomolecule and biological molecule analysis; robotic apparatus and instruments for genetic and DNA analysis; devices for analysing protein used as laboratory apparatus; devices for analysing biomolecules and biological molecules used as laboratory apparatus; devices for genetic and DNA analysis used as laboratory apparatus; computer software for protein analysis; computer software for biomolecule and biological molecule analysis; computer software for genetic and DNA analysis; protein analysis equipment comprising computer hardware, software, and display screens for protein detection, and analysis; biomolecule and biological molecule analysis equipment comprising computer hardware, software, and display screens for protein detection, and analysis; genetic and DNA analysis equipment comprising computer hardware, software, and display screens for protein detection, and analysis; protein analysis equipment comprising sensors for protein detection, and analysis; biomolecule and biological molecule analysis equipment comprising sensors for protein detection, and analysis; genetic and DNA analysis equipment comprising sensors for protein detection, and analysis; instruments containing electrical, computer and chemical hardware for the analysis of proteins; instruments containing electrical, computer and chemical hardware for the analysis of biomolecules and biological molecules; instruments containing electrical, computer and chemical hardware for genetic and DNA analysis; biosensors; biosensors for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, proteins; biosensors for use in biomolecular measurement, quantification, kinetics, protein analysis, clinical research applications, drug development and nucleic acid interaction, antibody and antibody fragment characterisation, protein- protein interactions, protein-peptide interactions, protein-DNA/RNA interactions, protein-lipid interactions, virus and vaccine research, protein-small molecule interactions, cell-based assays (cellular secretions in response to a protein presence); laboratory apparatus and instruments used for creating DNA libraries, RNA libraries, and proteins libraries; instruments containing electrical, computer and chemical hardware for the analysis of DNA, RNA, and cells; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and laboratory equipment for making molecular arrays; biosensors for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, oligonucleotides, DNA, RNA, cells, virus, aptamers, bacteria, antibodies and antibody fragments
1 Reagents for protein analysis; chemical reagents for use in genetic and DNA research; chemical reagents for non-medical purposes, namely, for analysing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates and functional properties of biomolecules, namely, chemical compounds, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, virus, bacteria, antibodies and antibody fragments; reagent kits for use in protein analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research; reagent kits for use in biomolecular analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research; reagent kits for use in genetic and DNA analysis, detection, identification, characterisation, and separation comprised of assays and reagents for use in genetic research, biomarker research, and antibody research
42 Research and development services; biotechnology research and development services; research and development in the field of biomolecular analysis; research and development in the field of protein analysis; research and development in the field of genetic and DNA analysis; drug development and drug discovery services; drug development and drug discovery services in the field of biomolecular sciences; consultancy and advisory services in the field of biomolecular analysis; consultancy and advisory services in the field of protein analysis; consultancy and advisory services relating to research and development in the field of therapeutics; consultancy and advisory services relating to research and development in the field of protein analysis; consultancy and advisory services relating to research and development in the field of biomolecule and biological molecule analysis; consultancy and advisory services relating to research and development in the field of genetic and DNA analysis; design and development of laboratory apparatus and instruments; design and development of laboratory apparatus and instruments and computer systems for use in the analysis of protein; design and development of laboratory apparatus and instruments and computer systems for use in the analysis of biomolecules and biological molecules; design and development of laboratory apparatus and instruments and computer systems for use in genetic and DNA analysis; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analysing proteins and other biological molecules; protein screening for scientific research purposes

Trademark Events
Mar 28, 2024
Sn Assigned For Sect 66a Appl From Ib
Mar 29, 2024
New Application Office Supplied Data Entered
Apr 2, 2024
Application Filing Receipt Mailed
Jun 11, 2024
Assigned To Examiner
Jun 12, 2024
Non-Final Action Written
Jun 15, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Jul 5, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Jul 28, 2024
Refusal Processed By Ib
Jul 5, 2024
Refusal Processed By Mpu

Trademark Alertz updated from USPTO on 2030-01-24